| pubmed-article:11762809 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11762809 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11762809 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:11762809 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:11762809 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:11762809 | lifeskim:mentions | umls-concept:C0699967 | lld:lifeskim |
| pubmed-article:11762809 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11762809 | pubmed:dateCreated | 2001-12-13 | lld:pubmed |
| pubmed-article:11762809 | pubmed:abstractText | Docetaxel (Taxotere) has demonstrated high antitumour activity in first- and second-line treatment of metastatic breast cancer. This study analysed the efficacy and toxicity of docetaxel given weekly. | lld:pubmed |
| pubmed-article:11762809 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11762809 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762809 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11762809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11762809 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11762809 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11762809 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:SommerHH | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:BischoffJJ | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:HiddemannWW | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:GutschowKK | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:HeinemannVV | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:Forstpointner... | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:GeuenichSS | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:StemmlerH JHJ | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:Malekmohammad... | lld:pubmed |
| pubmed-article:11762809 | pubmed:author | pubmed-author:KentenichC... | lld:pubmed |
| pubmed-article:11762809 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11762809 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:11762809 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11762809 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11762809 | pubmed:pagination | 1393-8 | lld:pubmed |
| pubmed-article:11762809 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:meshHeading | pubmed-meshheading:11762809... | lld:pubmed |
| pubmed-article:11762809 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11762809 | pubmed:articleTitle | Weekly docetaxel (Taxotere) in patients with metastatic breast cancer. | lld:pubmed |
| pubmed-article:11762809 | pubmed:affiliation | Department of Internal Medicine III Klinikum Grosshadern, University of Munich Germany. | lld:pubmed |
| pubmed-article:11762809 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11762809 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762809 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762809 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11762809 | lld:pubmed |
